147 related articles for article (PubMed ID: 2355304)
1. [Prolongation of theophylline derivative release with cellulose acetate based tablets].
Guyonnet T; Brossard C; Lefort des Ylouses D
J Pharm Belg; 1990; 45(2):111-9. PubMed ID: 2355304
[TBL] [Abstract][Full Text] [Related]
2. [Optimization of liberation of theophylline derivatives from Gelucire matrix tablets].
Ratsimbazafy V; Brossard C
Pharm Acta Helv; 1992; 67(5-6):166-71. PubMed ID: 1438455
[TBL] [Abstract][Full Text] [Related]
3. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
5. Characterization of chitosan acetate as a binder for sustained release tablets.
Nunthanid J; Laungtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S; Lim LY; Khor E
J Control Release; 2004 Sep; 99(1):15-26. PubMed ID: 15342177
[TBL] [Abstract][Full Text] [Related]
6. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
Mank R; Kala H; Richter M; Babel W; Sattler K
Pharmazie; 1989 Aug; 44(8):545-7. PubMed ID: 2594825
[TBL] [Abstract][Full Text] [Related]
8. Ethyl cellulose as a potential sustained release coating for oral pharmaceuticals.
Salib NN; El-menshaway ME; Ismail AA
Pharmazie; 1976; 31(10):721-3. PubMed ID: 1019195
[TBL] [Abstract][Full Text] [Related]
9. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
[TBL] [Abstract][Full Text] [Related]
10. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
[TBL] [Abstract][Full Text] [Related]
11. Per-oral controlled release dosage form of theophylline using soybean protein.
Machida Y; Tokumura T; Nagai T
Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
[TBL] [Abstract][Full Text] [Related]
12. Scleroglucan sustained-release oral preparations. Part I. In vitro experiments.
Touitou E; Alhaique F; Riccieri FM; Riccioni G; Santucci E
Drug Des Deliv; 1989 Dec; 5(2):141-8. PubMed ID: 2577984
[TBL] [Abstract][Full Text] [Related]
13. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
14. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
Vostalová L; Rabisková M; Medvecká G
Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
16. A study on maize proteins as a potential new tablet excipient.
Georget DM; Barker SA; Belton PS
Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
[TBL] [Abstract][Full Text] [Related]
17. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
Savaşer A; Ozkan Y; Işimer A
Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
[TBL] [Abstract][Full Text] [Related]
19. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
Emeje MO; Kunle OO; Ofoefule SI
Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
[TBL] [Abstract][Full Text] [Related]
20. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
